The German COVID-19 Digital Contact Tracing App: A Socioeconomic Evaluation.
COVID-19
Corona Warn App
cost–benefit analysis
digital contact tracing
utility analysis
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
02 11 2022
02 11 2022
Historique:
received:
20
09
2022
revised:
29
10
2022
accepted:
31
10
2022
entrez:
11
11
2022
pubmed:
12
11
2022
medline:
15
11
2022
Statut:
epublish
Résumé
The COVID-19 pandemic posed challenges to governments in terms of contact tracing. Like many other countries, Germany introduced a mobile-phone-based digital contact tracing solution ("Corona Warn App"; CWA) in June 2020. At the time of its release, however, it was hard to assess how effective such a solution would be, and a political and societal debate arose regarding its efficiency, also in light of its high costs. This study aimed to analyze the effectiveness of the CWA, considering prevented infections, hospitalizations, intensive care treatments, and deaths. In addition, its efficiency was to be assessed from a monetary point of view, and factors with a significant influence on the effectiveness and efficiency of the CWA were to be determined. Mathematical and statistical modeling was used to calculate infection cases prevented by the CWA, along with the numbers of prevented complications (hospitalizations, intensive care treatments, deaths) using publicly available CWA download numbers and incidences over time. The monetized benefits of these prevented cases were quantified and offset against the costs incurred. Sensitivity analysis was used to identify factors critically influencing these parameters. Between June 2020 and April 2022, the CWA prevented 1.41 million infections, 17,200 hospitalizations, 4600 intensive care treatments, and 7200 deaths. After offsetting costs and benefits, the CWA had a net present value of EUR 765 m in April 2022. Both the effectiveness and efficiency of the CWA are decisively and disproportionately positively influenced by the highest possible adoption rate among the population and a high rate of positive infection test results shared via the CWA.
Identifiants
pubmed: 36361198
pii: ijerph192114318
doi: 10.3390/ijerph192114318
pmc: PMC9654962
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Exp Mol Med. 2021 May;53(5):737-749
pubmed: 33953324
BMJ. 2022 Mar 9;376:e069761
pubmed: 35264324
Nat Hum Behav. 2021 Feb;5(2):247-255
pubmed: 33479505
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
Science. 2020 May 8;368(6491):
pubmed: 32234805
JAMA. 2021 Aug 24;326(8):766-767
pubmed: 34213530
Microorganisms. 2020 Aug 31;8(9):
pubmed: 32878286
J Empir Res Hum Res Ethics. 2022 Sep 7;:15562646221118127
pubmed: 36069118
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
JMIR Hum Factors. 2022 Sep 14;9(3):e35434
pubmed: 35862671
Lancet Infect Dis. 2021 Feb;21(2):193-202
pubmed: 33729915
BMJ. 2021 Jul 26;374:n1648
pubmed: 34312178
Lancet Infect Dis. 2022 Jan;22(1):35-42
pubmed: 34461056
Lancet. 2021 Jun 26;397(10293):2461-2462
pubmed: 34139198
Ethics Inf Technol. 2022;24(3):30
pubmed: 35915595
PLoS One. 2021 Feb 3;16(2):e0246524
pubmed: 33534839
Sci Rep. 2021 Dec 9;11(1):23763
pubmed: 34887456
Science. 2003 Jun 20;300(5627):1961-6
pubmed: 12766206
Lancet Infect Dis. 2022 May;22(5):603-610
pubmed: 35176230
Int J Environ Res Public Health. 2022 Jul 29;19(15):
pubmed: 35954664
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Sustain Cities Soc. 2021 Aug;71:102995
pubmed: 34002124
Lancet Infect Dis. 2022 Jan;22(1):43-55
pubmed: 34480857
Math Med Biol. 2022 Jun 11;39(2):156-168
pubmed: 35290447
Front Psychol. 2022 Jul 22;13:899092
pubmed: 35936321
J Infect Public Health. 2022 Apr 29;15(6):609-614
pubmed: 35537237
MMWR Morb Mortal Wkly Rep. 2021 Oct 29;70(43):1513-1519
pubmed: 34710076
Gov Inf Q. 2022 Oct;39(4):101750
pubmed: 35909915
Soc Sci Humanit Open. 2021;4(1):100212
pubmed: 34642660
JAMA Netw Open. 2021 Dec 1;4(12):e2137257
pubmed: 34905008
Lancet Public Health. 2020 Aug;5(8):e452-e459
pubmed: 32682487
PLoS One. 2021 Sep 2;16(9):e0256660
pubmed: 34473733
Nat Commun. 2021 Oct 11;12(1):5918
pubmed: 34635661
Int J Imaging Syst Technol. 2021 Jun;31(2):455-471
pubmed: 33821093
JMIR Mhealth Uhealth. 2022 Jul 12;10(7):e35195
pubmed: 35709334
IEEE Access. 2021 Apr 21;9:62956-62971
pubmed: 34812392
PLoS One. 2021 Jun 9;16(6):e0252373
pubmed: 34106993
BMJ Open. 2021 Jul 12;11(7):e050519
pubmed: 34253676
Lancet Digit Health. 2020 Aug;2(8):e395-e396
pubmed: 32835198
PeerJ Comput Sci. 2022 Jan 04;8:e826
pubmed: 35111915
Eur J Public Health. 2021 Feb 1;31(1):49-51
pubmed: 33340328
Lancet. 2022 Apr 2;399(10332):1303-1312
pubmed: 35305296
Am J Physiol Cell Physiol. 2022 Jan 1;322(1):C1-C11
pubmed: 34817268
Pan Afr Med J. 2022 May 09;42:18
pubmed: 35812253
Lancet Digit Health. 2020 Aug;2(8):e435-e440
pubmed: 32835201
Lancet Infect Dis. 2020 Oct;20(10):1151-1160
pubmed: 32559451
PLoS One. 2021 Jun 3;16(6):e0252729
pubmed: 34081757
Nat Med. 2021 Apr;27(4):601-615
pubmed: 33753937
PLoS One. 2020 Sep 30;15(9):e0239943
pubmed: 32997724
Comput Struct Biotechnol J. 2019 Jan 26;17:186-194
pubmed: 30809323
Nature. 2020 Jun;582(7810):29-31
pubmed: 32467596
Viruses. 2022 Jan 30;14(2):
pubmed: 35215887
Med Princ Pract. 2022 Aug 26;:
pubmed: 36030770